Detalles de la búsqueda
1.
Efficacy and safety of adapalene gel as a reactive treatment for cetuximab-induced skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck: A historical cohort comparison study.
J Oncol Pharm Pract
; 30(2): 295-303, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37098185
2.
Potential efficacy of local therapy for progressive lesions after nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Int J Clin Oncol
; 28(8): 1023-1032, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37344738
3.
IMAGENE trial: multicenter, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy of niraparib with PD-1 inhibitor in solid cancer patients with homologous recombination repair genes mutation.
BMC Cancer
; 22(1): 1292, 2022 Dec 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36494792
4.
Systemic therapy for salivary gland malignancy: current status and future perspectives.
Jpn J Clin Oncol
; 52(4): 293-302, 2022 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35134985
5.
Human papillomavirus-related oropharyngeal carcinoma.
Jpn J Clin Oncol
; 52(7): 700-706, 2022 07 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35383359
6.
Biweekly administration of cetuximab in Japanese patients with recurrent or metastatic head and neck cancer.
Int J Clin Oncol
; 27(11): 1669-1674, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35943644
7.
Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck.
Jpn J Clin Oncol
; 51(2): 173-179, 2021 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33290543
8.
A phase I, single-center, open-label study of RM-1929 photoimmunotherapy in Japanese patients with recurrent head and neck squamous cell carcinoma.
Int J Clin Oncol
; 26(10): 1812-1821, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34165660
9.
Immunotherapy for squamous cell carcinoma of the head and neck.
Jpn J Clin Oncol
; 50(10): 1089-1096, 2020 Sep 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32776100
10.
Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology.
Int J Clin Oncol
; 25(3): 403-417, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31974683
11.
A review of head and neck cancer staging system in the TNM classification of malignant tumors (eighth edition).
Jpn J Clin Oncol
; 49(7): 589-595, 2019 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31194232
12.
Induction TPF chemotherapy followed by CRT with fractionated administration of cisplatin in patients with unresectable locally advanced head and neck cancer.
Int J Clin Oncol
; 24(7): 789-797, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30796560
13.
Gemcitabine monotherapy in patients with heavily treated nasopharyngeal cancer: a case series.
Int J Clin Oncol
; 22(6): 1009-1014, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28616753
14.
[â ¤.Current Clinical Trials for Recurrent or Metastatic Head and Neck Squamous Cell Cancer].
Gan To Kagaku Ryoho
; 47(7): 1055-1058, 2020 Jul.
Artículo
en Japonés
| MEDLINE | ID: mdl-32668851
15.
Immunotherapy for head and neck cancer: Fundamentals and therapeutic development.
Auris Nasus Larynx
; 51(4): 684-695, 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38729034
16.
Long-term outcomes of patients with oral cavity cancer receiving postoperative radiotherapy after salvage neck dissection for cervical lymph node recurrence.
Head Neck
; 46(3): 541-551, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38108511
17.
Phase II study of cetuximab plus concomitant boost radiotherapy in Japanese patients with locally advanced squamous cell carcinoma of the head and neck.
Jpn J Clin Oncol
; 43(5): 476-82, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23479383
18.
[IV. The Current State and Prospect of Drug Therapy - Treatment Development of Recent Years].
Gan To Kagaku Ryoho
; 45(7): 1056-1060, 2018 Jul.
Artículo
en Japonés
| MEDLINE | ID: mdl-30042272
19.
Planned drug holidays during treatment with lenvatinib for radioiodine-refractory differentiated thyroid cancer: a retrospective study.
Front Oncol
; 13: 1139659, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37886165
20.
Impact of lenvatinib-induced proteinuria and renal dysfunction in patients with thyroid cancer.
Front Oncol
; 13: 1154771, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36998435